AddLife signs agreement with Wellspect HealthCare on acquisition of business in surgery and respiration
The Life Science group AddLife signed an agreement today with Wellspect HealthCare on the acquisition of its business in the product areas surgery and respiration. Under the agreement, AddLife is acquiring a number of market-leading niche products with associated rights and customer agreements in several geographic markets. The business has sales of about EUR 17 million, with eight markets in Europe and Australia accounting for more than 90 percent of sales. The acquisition is expected to be completed during the first quarter of 2019.AddLife is continuing its growth by acquiring market-